India's TB immunisation programme currently offers BCG vaccination at birth or as early as possible till one year of age.
The Drugs Controller General Of India has already approved Covovax for restricted use in emergency situations in adults on December 28.
Serum Institute produces AstraZeneca's Covid-19 vaccine under the brand name Covishield. The vaccine is one of India's two main vaccines against Covid pandemic under mass vaccination drive.
Globally, the supply of vaccines has outmatched the demand and to keep up with the momentum, countries need to join and form some agreement in order to prepare standard rules for clinical trials and manufacturing of the vaccines.
Further, Poonawalla said there was enough data to show that the vaccines will work and protect the children against the infectious disease.
According to the source, the Union government has allowed the commercial export of both vaccines - Covishield and Covaxin - in view of sufficient stock of the vaccines available with the states and Union Territories, and also with the manufacturers.
It was unethical to start giving the third booster dose of Covid vaccine to someone when others in certain countries and populations have not even got two doses for full vaccination, said Adar Poonawalla on Friday
As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center, which developed the Sputnik V jab.
India's Serum Institute is seeking emergency authorisation in the European Union for its Covishield jab, the BBC reported.
The Centre said that more than 30.54 crore vaccine doses have been provided to the states and Union Territories so far. According to the health ministry, 1,50,28,186 Covid doses are still available with the states and Union Territories to be administered.
Novavax Inc had announced that NVX-CoV2373, its recombinant nanoparticle protein-based Covid-19 vaccine, demonstrated 100 per cent protection against moderate and severe disease, 90.4 per cent efficacy overall.
The Drug Controller General of India (DCGI) on Friday granted Serum Institute of India (SII) the permission to manufacture Russian COVID Vaccine- Sputnik V for examination test and analysis at its licensed facility at Hadapsar, ANI quoted sources as saying.
London: Admitting that he is facing immense pressure from “some of the most powerful people in India” demanding supplies of Covishield, Serum Institute of India (SII) CEO Adar Poonawalla said on…
New Delhi: Serum Institute of India (SII) — the maker of the most used COVID-19 vaccine in the country — on Wednesday announced a cut in price of the jab…
Pune: In what could be a mega boost to the ongoing Covid-19 vaccination drive in India, the Serum Institute of India (SII) has announced its plan to launch its new vaccine, Covovax, by June this year. SII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent […]
New Delhi: As a beneficiary of India’s vaccine diplomacy, Sri Lanka will on Thursday receive a consignment of 500,000 doses of ‘Covishield’ vaccine manufactured by the Serum Institute of India (SII). This gift of Covid-19 vaccine doses to Sri Lanka is a part of India’s ‘Vaccine Maitri’ initiative under which India has gifted vaccines to […]
Pune: At least five persons suffocated to death as a major fire broke out in an under-construction building in a plant of global vaccine giant, the Serum Institute of India (SII), here on Thursday afternoon, shocking the country. Health Minister Rajesh Tope and Pune Mayor Murlidhar Mohol announced that five persons, including one woman, had […]
Kathmandu: A total of one million Covid-19 vaccines will be delivered by India to Nepal which will land in Kathmandu on Thursday, said the Nepalese Health and Population Minister Hrydesh Tripathi on Wednesday. Addressing a press conference along with Indian Ambassador to Nepal, Vinay Mohan Kwatra, Tripathi said the Government of India will hand over […]
New Delhi: Days before the commencement of the nationwide Covid-19 vaccination drive, the Union Health Ministry said on Tuesday that 1.1 crore Covishield and 55 lakh Covaxin vaccines have been procured at a cost of Rs 200 and Rs 206 per dose, respectively. However, BBIL will provide 16.5 lakh doses of Covaxin free of cost […]
Pune: A decisive phase in India’s fight against coronavirus began in the wee hours on Tuesday as the first consignment of Covishield vaccines left Serum Institute of India for Pune airport, four days ahead of the nationwide inoculation drive launch. Three temperature-controlled trucks rolled out of the Serum Institute gates shortly before 5 am and […]
New Delhi: Coronavirus vaccine developed by AstraZeneca and the University of Oxford will cost Rs 219-292 per shot to the government and will be priced at double that rate in private market ones such sales open up, said Adar Poonawalla, the CEO of its Indian manufacturer-Serum Institute of India, on Monday. Serum Institute of India […]
Bhubaneswar: In a major relief to the denizens, Covid-19 vaccination drive will kick start across Odisha as soon as the doses reach the State, informed Directorate of Medical Education & Training (DMET) Director Prof CBK Mohanty on Monday. The reaction from Mohanty came just a day after the Drug Controller General of India (DCGI) granted […]
New Delhi: Pune-based Serum Institute of India on Monday expressed hope at the possibility of Covid-19 vaccine – Covishield receiving the regulatory approval in “few days”, while emphasising that the company has a massive stockpile 40-50 million doses. The drug maker has partnered with global pharma giant AstraZeneca and the Oxford University for making the […]
New Delhi: The Serum Institute of India (SII) has submitted additional data required by the Drug Controller General of India (DCGI) for determining the safety and immunogenicity of its Covid-19 vaccine candidate, Covishield, sources privy to the development told IANS. The data was submitted few days ago to the Central Drugs Standard Control Organisation (CDSCO), […]
New Delhi: Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, said on Saturday that the country would require a massive funding of Rs 80,000 crore for distribution of the Covid vaccine for the next one year. The Central government plans to vaccinate nearly 30 crore people in the first […]
New Delhi: Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield. “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD. This will save countless lives, and I thank the Government of India and […]
New Delhi: After a Chennai-based volunteer served a legal notice to the Serum Institute of India (SII) demanding Rs 5 crore compensation for the alleged neurological complications he developed after being administered a test dose of its Covidshield vaccine, the SII has now countered the allegation with a demand of Rs 100 crore as damages […]
New Delhi: A further collaboration among the Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, Gavi and the Bill and Melinda Gates Foundation will accelerate the manufacture and delivery of up to 100 million doses of safe and effective Covid-19 vaccines for India and low-and middle income countries. This brings the […]
Pune: Adar Poonawalla, Chief Executive Officer of Serum Institute of India (SII) which is producing the potential coronavirus vaccine developed by Oxford University, asked on Saturday if the government will have Rs 80,000 crore available to buy and distribute the vaccine. “Quick question; will the government of India have 80,000 crores available, over the next […]
New Delhi: Drugs Controller General of India (DCGI) Dr V G Somani has gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial. The DCGI has, however, put certain […]
New Delhi: The Serum Institute of India (SII), which was conducting the India trials for the coronavirus vaccine being developed by Oxford University, on Thursday paused the clinical trials of the vaccine in India. In a statement, the Serum Institute of India said: “We are reviewing the situation and pausing India trials till AstraZeneca restarts […]
New Delhi: The central drug regulator has issued a show-cause notice to the Serum Institute of India (SII) for not informing it about pharma giant AstraZeneca pausing the clinical trials of the Oxford vaccine candidate for COVID-19 in other countries and also for not submitting casualty analysis of the “reported serious adverse events”. The show-cause […]
New Delhi: Serum Institute of India (SII), the worlds largest vaccine manufacturer by volume, has entered into a new landmark partnership with Gavi, The Vaccine Alliance and the Bill & Melinda Gates Foundation, to accelerate the manufacture and delivery of up to 100 million doses of COVID-19 vaccines for India and low- and middle-income countries […]
New Delhi: The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed COVID-19 vaccine candidate in the country. Government officials told PTI that the approval for conducting phase 2 and 3 clinical trials by […]
New Delhi: Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Department of Biotechnology (DBT) Secretary Renu Swarup said on Monday. This is an essential step because it is necessary to have data within the country before the vaccine is administered to Indians, […]
Bhubaneswar: Odisha Chief Minister Naveen Patnaik talked to Adar Poonawalla, CEO of Serum Institute over a video call today to discuss on progress of Covid vaccine. The Chief Minister expressed happiness that Serum Institute has partnered with Oxford University to develop Covid vaccine and sought his cooperation to begin early vaccination in Odisha once necessary […]